Literature DB >> 28768443

Neurobrucellosis.

Na Zheng1, Wei Wang1, Jia-Tang Zhang1, Ya Cao1, Long Shao1, Jiao-Jiao Jiang1, Xu-Sheng Huang1, Cheng-Lin Tian1, Sheng-Yuan Yu1.   

Abstract

PURPOSE: Neurobrucellosis (NB) is a rare complication of brucellosis. NB presents with avariety of clinical manifestations, and the symptoms are always atypical. Our aim was to analyze the demographic characteristics, clinical manifestations, laboratory findings, imaging findings, treatments and outcomes of patients with NB. MATERIAL AND
METHOD: We retrospectively reviewed the data from 17 patients with NB hospitalized at the Chinese People's Liberation Army General Hospital between 1 January 2005 and 31 October 2016.
RESULTS: The following symptoms were recorded: 10/17 (59%) patients had fever, and 9/17 (53%) patients had a disorder affecting urination and defecation. Involvement of the cranial nerves was documented in 12/17 (71%) patients. The positivity rates of the tests were as follows: serum standard tube agglutination (STA), 15/17 (88.2%); cerebrospinal fluid STA, 10/17 (59%). The radiologic findings were categorized into four types: normal, white matter changes, vascular insult and inflammatory changes. Patients were treated with different combinations of rifampicin, doxycycline, ceftriaxone sodium and sulphamethoxazole for a total of six months. Two (12%) patients deteriorated, and two (12%) patients were lost to follow-up. The remaining patients (76%) were cured, but sequelae occurred in six patients.
CONCLUSIONS: NB should be kept in mind in patients with autonomic dysfunction, especially disorders of urination and defecation. Hearing loss due to vestibulocochlear nerve injury seems to be typical for NB. The high incidence of sequelae may be related to a long disease course and the involvement of the central nervous system. Early detection, diagnosis and treatment could decrease mortality and sequelae.

Entities:  

Keywords:  Neurobrucellosis; clinical manifestations; imaging findings; laboratory findings; treatment

Mesh:

Substances:

Year:  2017        PMID: 28768443     DOI: 10.1080/00207454.2017.1363747

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  7 in total

1.  Vasculitis and neurobrucellosis: Evaluation of nine cases using radiologic findings.

Authors:  Sule Aydin Turkoglu; Siddika Halicioglu; Fatma Sirmatel; Murside Yildiz; Nebil Yildiz; Serpil Yildiz
Journal:  Brain Behav       Date:  2018-03-09       Impact factor: 2.708

2.  Ceftriaxone use in brucellosis: A case series.

Authors:  Daniah F Fatani; Walaa A Alsanoosi; Mazen A Badawi; Abrar K Thabit
Journal:  IDCases       Date:  2019-09-05

3.  Identification of Dendritic Cell Maturation, TLR, and TREM1 Signaling Pathways in the Brucella canis Infected Canine Macrophage Cells, DH82, Through Transcriptomic Analysis.

Authors:  Woo Bin Park; Suji Kim; Soojin Shim; Han Sang Yoo
Journal:  Front Vet Sci       Date:  2021-03-19

4.  A Death Due to Neurobrucellosis - Linfen City, Shanxi Province, China, May 2021.

Authors:  Yufeng Du; Hongxia Yang; Hai Jiang; Xiufang Du
Journal:  China CDC Wkly       Date:  2021-12-31

5.  Identification of cerebrospinal fluid metabolites as biomarkers for neurobrucellosis by liquid chromatography-mass spectrometry approach.

Authors:  Hao Yang; Zhenfei Wang; Shujun Shi; Qin Yu; Meiling Liu; Zhelin Zhang
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

6.  Neurobrucellosis: the great mimicker.

Authors:  Cristiane Nascimento Soares; Abraão Iuri Medeiros Angelim; Carlos Otavio Brandão; Roberto Queiroz Santos; Ravi Mehta; Marcus Tulius Teixeira da Silva
Journal:  Rev Soc Bras Med Trop       Date:  2022-04-08       Impact factor: 2.141

7.  A Case of Cerebral Granuloma and Optic Papillitis due to Brucella sp.

Authors:  A Chiappe-Gonzalez; A Solano-Loza
Journal:  Case Rep Infect Dis       Date:  2020-07-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.